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1. Introduction
The liver plays an astonishing array of  vital  functions in the maintenance and perform‐
ance of the body. Additionally, it is also handling the metabolism and excretion of drugs
and other xenobiotics from the body thereby providing protection against foreign substan‐
ces by detoxifying and eliminating them (saleem et al., 2010). Large numbers of xenobiot‐
ics are reported to be potentially hepatotoxic. Free radicals generated from the xenobiotic
metabolism can induce lesions of  the liver and react  with the basic cellular constituents
such as proteins, lipids, RNA and DNA (Ajith et al., 2007). A growing international health
concern is Tuberculosis caused by Mycobacterium tuberculosis (Abdelaal et al., 2009).India is
the highest TB burden country accounting for one fifth (21%) of the global incidence (WHO,
2010).  The  first  line  anti-tuberculosis  drugs  isoniazid  (INH),  rifampicin  (RIF),  pyrazina‐
mide (PZA) and Ethambutol(ETH)continues to be the effective drugs in the treatment of
tuberculosis, however, the use of these drugs is associated with toxic reactions in tissues,
particularly in the liver, leading to hepatitis (Eminzade et al., 2008). This is one of the most
serious adverse effects of anti-tuberculosis drugs (ATD). Liver injury or liver dysfunction
is a major health problem that challenges not only health care professionals but also the
pharmaceutical  industry  and drug regulatory  agencies  (saleem et  al.,  2010).  It  has  great
capacity to detoxify and synthesize useful substances, and therefore damage to the liver
has  grave  consequences  (Devaraj  et  al.,  2011).  Currently,  there  is  no  effective  treatment
against  ATD induced hepatic  damage.  Plants are an important component of  the health
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care  system in  India  and have  been  found to  be  effective  in  the  treatment  of  different
diseases  and  are  the  beacon  of  the  therapeutic  sources  for  curing  diseases  from  times
immemorial (Merina et al.,  2012).  Phyllanthus amarus  Linn. is commonly known as bhumi
amla  (Joshi&Parle2007).  It  is  reported  to  possess  antiviral  (Lee  et  al.,  1996),  anticancer
(Rajeshkumar et al., 2002). But there is no scientific evidence for its hepatoprotective activity
against ATD induced liver injury. Hence the present study was undertaken to explore the
key  behind  the  use  of  P.amarus  as  a  hepatoprotective  formulation  against  xenobiotics
induced hepatic adverse effect.
2. Materials and methods
2.1. Chemicals
Anti TB drug i.e, Rifampicin, Isoniazid, Pyrazinamide as anti TB kit was generously obtained
from Government TB hospital, Gwalior (M.P.). All the other chemicals used in this study
were of analytical grade and were procured from Sigma–Aldrich (USA), E Merck (Germa‐
ny), Ranbaxy Pvt. Ltd. and BDH Company (India).
2.2. Preparation of plant extract
Whole plant of Phyllanthus amarus  was obtained from the authenticated ayurvedic dealer
and was identified by the experts of Botany Department, Jiwaji University Gwalior, India.
The shade dried plant was pulverized and extracted with 75% alcohol for 10 days with
concomitant shaking and then filtered. The filtrate was evaporated in vacuum to yield a
brownish powder (P.  amarus)  powder it  was stored in refrigerator at  4°C and adminis‐
tered orally according to body weight of animals at different concentration.
2.3. Animal maintenance and feeding
Female  albino  rats  of  Sprague  Dawley  strain  (160±10  g,  b.w.)  were  used  for  the  present
investigation.  Animals  were  housed  in  polypropylene  cages  under  standard  conditions
(25±2°C temperature, 60%-70% relative humidity and 14 h light and 10 h dark) and were
fed on standard pellet diet (Pranav Agro Industries Ltd., New Delhi, India) and drinking
water ad libitum. Animals used in this study were treated and cared for in accordance with
the guidelines recommended by the Committee for the Purpose of Control and Supervi‐
sion  of  Experiments  on  Animals  (CPCSEA),  Government  of  India,  Ministry  of  Culture,
Chennai.
2.4. Experimental design
Animals were divided into various groups of six animals each. P.amarus and anti TB drugs
were given alternatively for 8 weeks (3 days/week). The groups were treated as follows:
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Group I: Control (normal saline, 0.9%).
Group II: Per se - 400mg/kg, b.w., P.amarus (p.o.), daily.
Group III:  Experimental control-RIF+INH+PZA+ETH at 52, 70,175,140 mg/kg, b.w., (p.o.),
3days/week.
Group VI- VII: INH+RIF+PZA (as in group III) + P.amarus at 100, 200, 300 and 400 mg/kg,
b.w., (p.o) 3days/week.
Group VIII: Positive control-Silymerin -50mg/kg b.w. (p.o.), daily.
All the animals were euthanized 24hours after the last treatment to perform various biochem‐
ical and histological analysis.
2.4.1. Blood biochemical investigations
Blood was drawn from retro-orbital venous sinus and serum was isolated. Serum Urea, Uric
acid and Creatinine determined by commercially prepared kit method (E-Merck, Germany).
Serum AST and ALT activity were determined with Reitman and Frankel, 1957.
2.4.2. Tissue biochemical investigations
The tissues viz., liver and kidney were quickly excised, washed in ice cold, normal saline and
blotted individually freed from extraneous material on ash-free filter paper. The tissues were
then homogenized separately in hypotonic buffer (0.008% NaHCO3), pH 7.4, using a Potter-
Elvejham homogenizer at 600-1000 rpm in ice cold conditions.
The  crude  tissue  homogenate  was  centrifuged  at  2000  rpm  for  15  min  (0-4°C).  The
supernatant was collected and stored at- 20°C until  used for estimating tissue biochemi‐
cal parameters. Lipid Peroxidation (LPO) was determined by measuring thiobarbituric acid
reactive substances (TBARS) in tissues according to Sharma and Krishnamurthy, 1968.SOD
and Catalase activity were determined according to Misra and Fridovich, 1972 and Aebi,
1974 respectively.
2.4.3. Histopathological investigations
Tissues were fixed with Bouin’s solution. They were later sectioned using a microtome,
dehydrated in graded alcohol, embedded in paraffin section, and stained with hemotoxylin
and Eosin (H & E).
2.5. Statistical analysis
Results are presented as mean ± S.E. of six animals used in each group. Data were subjected
to statistical analysis through one-way analysis of variance (ANOVA) at 5% significance level
followed by Student’s t-test at p≤ 0.05( Snedecor and Cochran,1989).
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3. Results — Table 1-6 and histopathology
Treatment AST (IU/L) ALT (IU/L)
Group I 69 ± 3.81 52 ± 2.87
Group II 74 ± 4.09 53.6±2.96
Group III 345±19.07# 188 ± 10.39#
Group IV 120.22 ± 6.65* 81 ± 4.48*(81.44%) (78.67%)
Group V 112.34 ± 6.21* 71 ± 3.92*(84.29%) (86.02%)
Group VI 100.7 ± 5.57* 63 ± 3.48*(88.51%) (91.91%)
Group VII 94.4± 5.22* 60 ± 3.32*(90.79%) (94.11%)
Group VIII 83 ± 4.59* 59 ± 3.26*(94.92%) (94.85%)
ANOVA F Value 141.88@ 90.172@
Data are mean ± S.E., n=6.ANOVA (F Values at 5% level). # P≤0.05 vs. Control,*P ≤0.05 vs. ATD, @ Significant
Table 1. Therapeutic effect of P.amarus against ATD induced blood biochemical alterations
Treatment SALP (U/L) Albumin (g/dl) Bilirubin(mg/dl)
Group I 193.3±10.68 4.1 ± 0.23 0.19 ± 0.010
Group II 220±12.16 4.0 ± 0.22 0.2±0.011
Group III 462±25.54# 3.0±0.17# 0.8± 0.044#
Group IV
381.3±21.08* 3.5 ± 0.19 0.65± 0.036*
(30.03%) (45.45%) (24.59%)
Group V
305.25±16.87* 3.6 ± 0.199 0.58 ± 0.032*
(58.33%) (54.54%) (36.06%)
Group VI
257±14.21* 3.7 ± 0.20* 0.34± 0.018*
(76.29%) (63.63%) (75.4%)
Group VII
236±13.05* 3.8± 0.21* 0.32 ± 0.017*
(84.10%) (72.72%) (78.68%)
Group VIII
216±11.94* 4.0± 0.22* 0.3 ± 0.016*
(91.55%) (90.9%) (81.96%)
ANOVA F Value 39.135@ 3.631@ 89.61@
Table 2. Curative effect of P.amarus against ATD on selected serological parameters serum
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Treatment Urea (mg/dl) Uric acid (mg/dl) Creatinine (mg/dl)
Group I 19.5±1.08 5.3± 0.292 0.4± 0.022
Group II 24±1.33 5.6± 0.309 0.5±0.027
Group III 52.6±2.91# 10±0.552# 0.8± 0.044#
Group IV 47±2.59 7.6± 0.420* 0.7± 0.038*(16.91%) (51.06%) (25%)
Group V 44.1±2.44* 6.22± 0.343* 0.66± 0.036*(25.67%) (80.42%) (35%)
Group VI 35.7±1.97* 6.1± 0.337* 0.6± 0.033*(51.05%) (82.97%) (66%)
Group VII 30.7±1.70* 6± 0.331* 0.575± 0.032*(66.16%) (88.90%) (75%)
Group VIII 27.8±1.544* 5.8± 0.320* 0.55± 0.030*(74.92%) (89.36%) (83%)
ANOVA F Value 32.005@ 20.642@ 16.887@
Data are mean ± S.E., n=6.ANOVA (F Values at 5% level).# P≤0.05 vs. Control,*P ≤0.05 vs. ATD,@ Significant
Table 3. P.amarus efficiency in reducing Anti TB drugs induced renal alterations.
Treatment
Lipid Peroxidation Reduced glutathione
(n mole of TBARS/mg protein) (µ mole / g)
Liver Kidney Liver Kidney
Group I 0.31±0.017 0.3± 0.016 7.97± 0.441 7.5± 0.441
Group II 0.341±0.018 0.33± 0.018 8.136±0.449 7.78± 0.449
Group III 1.94±0.107# 1.28±0.071# 6.8± 0.376# 6.17± 0.376#
Group IV 0.69±0.038* 1.096± 0.061* 7.08± 0.391 6.69± 0.391(76.68%) (18.77%) (23.93%) (39.09%)
Group V 0.57±0.034* 1.096± 0.061* 7.18± 0.396 7.0± 0.397(84.04%) (18.77%) (32.47%) (62.40%)
Group VI 0.44±0.0243* 0.737± 0.041* 7.4± 0.409 7.25± 0.409(92.02%) (55.47%) (51.28%) (81.20%)
Group VII 0.431±0.0238* 0.721± 0.039* 7.75± 0.428 7.33± 0.428(92.57%) (57.04%) (81.19%) (87.21%)
Group VIII 0.335±0.018* 0.665± 0.037* 7.85± 0.434 7.34± 0.434(98.46%) (62.75%) (89.74%) (87.96%)
ANOVA F
Value 174.79@ 70.42@ 1.566 1.971
Data are mean ± S.E., n=6.ANOVA (F Values at 5% level).# P≤0.05 vs. Control,*P ≤0.05 vs. ATD,@ Significant
Table 4. Effect of P.amarus against AT drugs treated animals in tissue biochemical estimations.





(U/min./mg protein) (µ mole of H2O2 oxidised/min/mg protein)
Liver Kidney Liver Kidney
Group I 70.7±3.908 48.78± 2.696 50.7± 2.802 70.1± 3.875
Group II 76±4.201 51.2± 2.830 51.8±2.863 62.14± 3.435
Group III 37.52±2.074# 24.39±1.348# 38.1± 2.106# 50.8± 2.808#
Group IV 44±2.432 33.3± 1.840* 42.02± 2.322 59.67± 3.298(19.52%) (36.53%) (31.11%) (45.95%)
Group V 45.6±2.520 35.9± 1.984* 42.5± 2.349 59.97± 3.315(24.35%) (47.19%) (34.92%) (47.51%)
Group VI 55±3.040* 41.15± 2.274* 44.05± 2.435 61.96± 3.425*(52.68%) (68.71%) (47.22%) (57.82%)
Group VII 60.9±3.366* 43.13± 2.384* 45.2± 2.498 62.1± 3.432*(70.46%) (76.83%) (56.34%) (58.54%)
Group VIII 68±3.759* 41.83± 2.312* 50.6± 2.775* 62.57± 3.458*(91.86%) (71.50%) (96.03%) (58.54%)
ANOVA F
Value 22.664@ 12.569@ 4.464@ 2.911@
Data are mean ± S.E., n=6.ANOVA (F Values at 5% level).# P≤0.05 vs. Control,*P ≤0.05 vs. ATD,@ Significant
Table 5. Effect of P.amarus on SOD, Catalase activity in liver and kidney against anti TB drugs.
Treatment ATPase Liver ATPase Kidney(mgPi/100gm/min)
Group I 1971±108.95 2449.99±135.44
Group II 2114±116.86 2257.14±124.77
Group III 1335.71±73.84# 1785.7±98.72#
Group IV 1721.4± 95.16* 1814.28±100.29(60.71%) (4.30%)
Group V 1864.28±103.06* 1907.14±105.43(83.02%) (18.28%)
Group VI 1889±104.43* 2042.85±112.93(87.09%) (38.71%)
Group VII 1966.06±108.69* 2149.99±118.85*(99.22%) (54.83%)
Group VIII 1969±108.85* 2107.14 ±116.48(99.68%) (48.38%)
ANOVA F Value 6.350@ 4.696@
Data are mean ± S.E., n=6.ANOVA (F Values at 5% level). # P≤0.05 vs. Control,*P ≤0.05 vs. ATD, @ Significant.
Table 6. Therapeutic Effect of P.amarus on ATPase against ATD
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4. Discussion
The liver diseases remain one of the serious health problems as variedly exposed to xenobiotics.
Modern medicines have little to offer for alleviation of hepatic diseases. Although P. amarus
is reported to possess varied medicinal properties such as antiviral, anticancer, antioxidant,
anti-inflammatory, hepatoprotective (Joshi and Parle, 2007), there is no previous report about
the hepatoprotective activity of this plant against anti TB drugs. The present investigation
reports the hepatoprotective effect of P.amarus. In the present study, hepatotoxicity model in
albino rats was successfully produced by administering RIF, INH and PZA.
Effects of administration of Anti TB Drugs and Phyllanthus amarus orally on selected biochem‐
ical parameters in rat tissue and blood serum is presented in Table 1-6.
Significant rise above the normal upper limits in the measured serum transaminases in toxicant
group on day 60 of the experiment was a biochemical indication of liver injury. Elevated levels
of serum enzymes, AST and ALT are indicative of cellular leakage, and loss of functional
integrity of cell membrane in liver (Ranawat et al., 2010). Oral administration of P. amarus
extract at doses (100, 200, 300 and 400 mg/kg) showed significant recoupment in a dose
dependent manner (P ≤0.05) (Table1).
The increased level of serum alkaline phosphatase is reliable marker of liver damage, which
occurs due to the de novo synthesis by the liver cells (Muriel and Escobar, 2003). Serum albumin
concentration is affected by hepatic protein and its synthesis is a typical function of normal
liver cells (Thirunavukkarasu and Skthisenkaran, 2003). Bilirubin is one of the most frequent
clinical test to evaluate the extent of chemically induced hepatotoxicity (Zimmerman, 1973).
Toxicants administration caused significant increase in the serum alkaline phosphatase
activity. Stabilization of SALP and bilirubin levels by the treatment of P.amarus is clear
indication of improvement in functional status of liver cells. Results suggested that P.amarus
at a dose of 400mg/kg, b.w., have protective effect on plasma membrane of hepatocytes.
(Table2)
As a measure of renal function status, serum urea, uric acid and creatinine are often regarded
as reliable markers (Adebisi et al., 2000). Serum creatinine has been used to estimate glomerular
filtration rate. Thus, elevations in the serum concentrations of these markers are indicative of
renal injury (Adebisi et al., 2000; Adewole et al., 2007).The same was observed after toxicant
administration. It may be due to dysfunctional and dystrophic changes in the liver and kidney.
Experiment has shown that P.amarus at different doses, showed significant protective but the
highest protection was obsereved at 300 and 400 mg/kg with mere difference indicating normal
glomerular filtration rate thereby improved functional status of kidney. (Table 3)
Various biochemical parameters were measured in liver and kidney tissues. The levels of
TBARS in liver and kidney tissues of ATD intoxicated rats were significantly elevated when
compared to the level of TBARS in control animals. The increased lipid peroxidation results
in changes in cellular metabolism of the hepatic and extra hepatic tissues, which ultimately
leads to the whole cell deformity and cell death (Arun and Balasubramanian, 2011). The
administration of herbal drug P. amarus at the different therapeutic doses showed reduction
Hepatoprotective effect of Phyllanthus amarus
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in TBARS level. The standard hepatoprotective drug Silymarin maintained the decreased lipid
peroxidation level to the normal limits in the liver.
Concomitant  cellular  oxidative  stress  was  manifested  by  reduced  GSH  levels  and  in‐
creased lipid peroxidation. The inverse linear relationship between the ROS level and the
GSH level indicated that free radical species were generated by exposure to anti TB drugs
which reduced intracellular antioxidant levels.  The results indicate that,  the herbal  drug
Phyllanthus amarus has very good hepatoprotective effect in liver damage. The results were
presented in the Table 4.
Superoxide dismutase and Catalase mutually function as important enzymes in elimination
of Reactive oxygen species (ROS). SOD is the major attractive metalloprotein in the antioxidant
family. The defensive antioxidant enzyme next to SOD is CAT. CAT is an enzymatic antioxi‐
dant widely distributed in all animal tissues, and the highest activity is found in the red cells
and liver. Both are the key component of the antioxidant defense system. In the present study,
the observed decrease in SOD and CAT activities were presumably associated with the
increased oxidative stress caused by these toxicants that might be due to low level of zinc (a
metal constituent of the enzyme SOD) in liver tissue (Arun and Balasubramanian, 2011)
Therapy at 200-400 mg/kg b.w. reversed the SOD and CAT activity in the liver tissues and
protected from free radical induced oxidative stress. These observations are substantiated by
author (Gnanadesigan et al., 2011).(Table 5)
ATPase is a membrane bound enzyme. Since, phosphatase is a constituent of all the body
tissues; it plays an important role in inorganic pyrophosphates activity. ATPase activity may
be considered as a marker for assessing hepatocellular damage induced by hepatotoxic agents.
(Table 6)
In our experiment, a concurrent fall was found in ATPase in liver after toxicants exposure. It
might be due to dysfunctional and dystrophic changes in the mitochondria and cell membrane
permeability. This damage was also very clearly visible in histopathological studies after
toxicant administration. These observations are substantiated by other authors (Gao and Zhou,
2005; Krithika and Verma, 2009).The effect of the extracts on ATPase was as pronounced with
100mg/kg as with 200-400mg/kg b.w.
Liver damage induced by toxicant was associated with a variety of biochemical abnormalities
following loss of integrity of the cell membrane or interference with normal hepatocytes
metabolism and function.
The reason for hepatoprotective effect of the extracts may be due to presence of lignans and
flavonoids which might have scavenged the free radical offering hepato protection.
5. Conclusion
The results of this study showed that common medicinal plant, P. amarus even at minimal dose
300mg/kg was found to have beneficial hepatoprotective properties in albino rats as all the
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major parameters showed percent protection level above 50% at dose levels 300 and
400mg/kg. All these properties make P. amarus, a novel herb for treating oxidative stress and
anti Tb drug associated hepatic toxicity. There is, however, the need of further experiments
for chronic study to exercise on excessive and prolonged use of this plant.
6. Histopathological studies
Figure 1. Hepatocytes of the normal control group showed a normal lobular architecture of the liver (400 x).
Figure 2. Hepatocytes of the INH + RIF+ PZA treated group showed liver cell necrosis and inflammation also observed
in the centrilobular region with portal triaditis (400 x).
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Figure 3. Hepatocytes of the P.amarus treated group showed cuboidal hepatocytes with moderate portal triaditis and
their lobular architecture was normal (400 x).
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